| Date | Title | Description |
| 07.09.2026 | US politician reveals 6 new suspicious stock trades |
Representative David J. Taylor, a Republican from Ohio, has reported six congressional stock trades, selling off holdings in biotech and technology while purchasing shares in utility, semiconductor, and a regional bank.
Taylor revealed sto... |
| 27.08.2026 | Tezspire CROSSING trial met primary endpoints | Tezspire CROSSING trial met primary endpoints
Thu, Aug 27, 2026 08:15 CET Report this content
27 August 2026
Tezspire demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints... |
| 14.08.2026 | Drug Trial Data Manipulation Wiped Avacopan’s EU Approval as FDA Hearing Looms | By Alfredo Hanson
Published: Aug 14 2026, 11:09 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 05.08.2026 | Biweekly GLP-1 Drug Clears First Human Test via Dual Fatty Acid Engineering | By Scott McCain
Published: Aug 05 2026, 9:01 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 01.08.2026 | Amgen discloses data breach involving patient health information | July 31 : Drugmaker Amgen said on Friday hackers stole company data and patient health information in a cybersecurity incident involving cloud storage systems run by third-party providers, becoming the latest healthcare firm to disclose a b... |
| 01.08.2026 | Amgen Patient PHI Stolen via Vendor Cloud: HIPAA and SEC Clocks Both Running | By Scott McCain
Published: Aug 01 2026, 1:50 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 26.07.2026 | Colorado was the first state to cap a drug’s price – then a federal court stepped in (Opinion) | Getting your Trinity Audio player ready...
By Shweta Kumar
Colorado is one of a handful of states with a review board for drug prices and one of only four with a board empowered to set upper limits on what state agencies, insurers and other... |
| 24.07.2026 | Чтение на выходные: «Великие по собственному выбору» Джима Коллинза и Мортена Хансена | Сегодня расскажем про книгу для тех, кто устал ждать, пока мир станет стабильным. Она не даст гарантий, но напомнит: великими становятся по собственному выбору.
Джим Коллинз и Мортен Хансен — исследователи в области менеджмента, чьи книги с... |
| 19.07.2026 | Copay assistance is meant to defray patient drug costs. Some insurers keep it instead | Getting your Trinity Audio player ready...
By Daniel Chang, KFF Health News
For 16 years, Larry Gruber, a fitness coach from Wilton Manors, Florida, received a coupon card to help him pay for a psoriatic arthritis medication he needs that c... |
| 16.07.2026 | FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients | Getting your Trinity Audio player ready...
By MATTHEW PERRONE, AP Health Writer
WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that’s previously only... |
| 09.07.2026 | Immunotherapy Drugs Market to Reach $580.6 Billion by 2029 | The global Immunotherapy drugs market is projected to grow from USD 285.3 billion in 2024 to USD 580.6 billion by 2029, at a robust CAGR of 15.3% during the forecast period. Market growth is driven by advancements in antibody engineering te... |
| 07.07.2026 | Colorado can’t cap price of arthritis drug Enbrel, federal judge rules | Getting your Trinity Audio player ready...
Colorado can’t cap the price of arthritis medication Enbrel while a lawsuit challenging the state’s drug affordability board’s action plays out, a federal judge ruled last week.
In 2024, the Colora... |
| 06.07.2026 | Онкопациенты выше всего оценили репутацию Roche, AstraZeneca и Novartis | Онкопациенты выше всего оценили репутацию Roche, AstraZeneca и Novartis
Исследовательская компания PatientView представила ежегодный рейтинг репутации фармкомпаний в онкологии. В нем 505 пациентских организаций из разных стран, работающих в... |
| 02.07.2026 | Biotech and Food companies strengthen management teams on the business side |
Basel-based pharma company Idorsia has appointed Roland Wandeler as CEO, effective October 1, 2026. He will succeed Jean-Paul Clozel, who has been serving as ad interim CEO since March 2026 and will continue as Chairman of the Board of Dir... |
| 26.06.2026 | Seven Boson Group Launches Sovereign AI Decision Intelligence Service for the AGI Era | Ltd. today announced the launch of its Sovereign AI Decision Intelligence software and services, enabling nations to own, deploy, and govern frontier AI without dependency on foreign providers.
The launch arrives at a pivotal moment: on Jun... |
| 26.06.2026 | CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union | Recommendation follows an Article 20 non-pharmacovigilance procedure
Patients currently on TAVNEOS treatment should consult their treating physician
ST. GALLEN, Switzerland, June 26, 2026 /PRNewswire/ -- Vifor Fresenius Medical Care Renal P... |
| 16.06.2026 | Colorado receives FDA permission to import cheaper drugs — including Ozempic — from Canada | Getting your Trinity Audio player ready...
Colorado finally has federal permission to start importing cheaper prescription drugs from Canada, but the state may not have any sellers to work with.
Lawmakers passed a bill in 2019 that directed... |
| 15.06.2026 | Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape | The case, originally filed in 2021 by Harbour Antibodies, asserted that Amgen and Teneobio (an Amgen subsidiary) infringed patents protecting Harbour's groundbreaking antibody discovery platform
Delaware jury finds infringement willful and ... |
| 13.06.2026 | Drugmakers race to find a place in the next wave of obesity drugs | Eli Lilly, Novo Nordisk, Amgen, Zealand, Structure Therapeutics shared their visions for the future of obesity medicine.
Drugmakers pitched doctors and investors on their future drugs at the recent American Diabetes Association (ADA) Scient... |
| 13.06.2026 | Global Heart Hub finds women delay seeking heart care by continuing to put others first | Heart symptoms continue to be dismissed or mistaken for other conditions, such as anxiety, new global patient-led research reveals.
Findings were presented at the European Society of Cardiology's ACNAP Congress 2026, organised by the Associ... |
| 27.05.2026 | Ember LifeSciences Expand Series A to $27M | Ember LifeSciences, Inc., a Los Angeles, CA-based healthcare technology company that specializes in cold chain logistics, raised an undisclosed amount in Series A extension funding.
The round was led by Amgen Ventures and TDF Ventures.
The ... |
| 16.05.2026 | CU Boulder sees 11th startup reach $1 billion unicorn status | Getting your Trinity Audio player ready...
Forge Nano, an advanced materials company and University of Colorado Boulder startup, has reached a $1.6 billion valuation, making it CU Boulder’s 11th “unicorn,” or a privately held company with a... |
| 07.05.2026 | Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance Global Scientific Strategy and Innovation | CAMBRIDGE, Mass., May 7, 2026 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the app... |
| 24.04.2026 | Four Swiss companies appoint new CEOs across tech and pharma |
Altoo, a Swiss wealth management platform that consolidates financial data across banking, investments and alternative holdings into a single digital interface, has appointed Achille Deodato as Chief Executive Officer. Deodato succeeds Ian... |
| 22.04.2026 | 5 Things to Know
Ceasefire extension, Best Buy’s new CEO, Amazon’s GLP-1 push and more in Morning Squawk | This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox.
Happy Wednesday. With all the volatility in the oil market, I found it helpful to look at this timeline for a reminder of all that’s happened... |
| 21.04.2026 | Amazon launches GLP-1 weight loss program, promising ‘fast, convenient’ access | Amazon One Medical launched a GLP-1 program integrating obesity care with Amazon Pharmacy.
Pricing for the popular weight loss drugs will begin at as low as $25 per month with insurance.
Shares of Hims & Hers Health, Viking Therapeutics... |
| 16.04.2026 | OpenAI debuts GPT-Rosalind, a new limited access model for life sciences, and broader Codex plugin on Github | The journey from a laboratory hypothesis to a pharmacy shelf is one of the most grueling marathons in modern industry, typically spanning 10 to 15 years and billions of dollars in investment.
Progress is often stymied not just by the inhere... |
| 08.04.2026 | Swiss startups appoint new CEOs and senior hires across biotech, AI and proptech |
Anaveon, a pre-clinical biotechnology company developing immune-modulating therapies for autoimmune and inflammatory disorders, has appointed Thaminda Ramanayake as Chief Executive Officer. Ramanayake succeeds Andreas Katopodis, who led th... |
| 30.03.2026 | Blackstone: $6.3 Billion Life Sciences Fund Closed As Largest Private Vehicle In Sector | Blackstone announced the final close of its latest life sciences fund, Blackstone Life Sciences VI, at $6.3 billion, marking the largest private fund ever dedicated to the life sciences sector. The fund reached its hard cap and was oversubs... |
| 24.03.2026 |
OpenAI raises additional money to bring record funding round to $120 billion, CFO tells Cramer | Monday - Friday, 6:00 - 7:00 PM ET
OpenAI CFO Sarah Friar told CNBC’s Jim Cramer that the startup is raising an additional $10 billion from investors.
“It didn’t matter where you went, people really believed in this AI revolution and they w... |
| 03.03.2026 | Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform | NEW YORK, March 3, 2026 /PRNewswire/ -- Royalty Pharma plc (Nasdaq: RPRX) announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company's royalty ... |
| 25.02.2026 | These 4 charts show the scale of Novo Nordisk’s woes | Pricing pressure, fierce competition, and pipeline setbacks are all weighing on Novo Nordisk.
The Danish company is less diversified than current and future competitors, and increasingly exposed to the U.S. market, where drug prices are com... |
| 20.02.2026 | Buy this best-in-class GLP-1 leader as competition heats up, says Barclays | - |
| 20.02.2026 | Curt Smith: Fighting blood cancer is easier with a group effort | - |
| 16.02.2026 | ZAKA VC Backs DeepSeq.AI’s Functional Approach to Protein Drug Discovery | ZAKA VC backs DeepSeq.AI’s hyperscaled functional data application for AI-driven protein drug discovery The founding team combines AI innovation, biological screening, and commercial biotech leadership The platform focuses on function, not ... |
| 13.02.2026 | Prices, pipelines and patent cliffs: Inside pharma’s big reset | Pharma earnings weren’t the main focus for drugmakers this quarter.
“2025 was about understanding kind of the rules of the future of the game,” McKinsey Senior Partner Greg Graves told CNBC.
In addition to political dealings, companies are ... |
| 06.02.2026 | PDA Introduces the 2026 Board of Directors and Officers | PDA's diverse Board of Directors brings a diverse set of interests, expertise, and experiences.
BETHESDA, Md., Feb. 6, 2026 /PRNewswire-PRWeb/ -- PDA is excited to introduce the all-volunteer 2026 Board of Directors and Officers following f... |
| 06.02.2026 | Cramer calls this drug maker the ‘greatest growth stock.’ He also names a runner-up | - |
| 03.02.2026 | Stocks making the biggest moves after hours: Chipotle, Advanced Micro Devices, Amgen and more | - |
| 30.01.2026 | PharmNovo enhances its Board ahead of Phase II development | PharmNovo enhances its Board ahead of Phase II development
Fri, Jan 30, 2026 08:04 CET Report this content
PharmNovo AB announces changes to its Board of Directors, welcoming two new members as the company prepares for its next phase of cli... |
| 24.01.2026 | Heart Attack Survivor and Social Media Powerhouse Dr. ShantaQuilette Carter-Williams to Take Center Stage at WomenHeart's 2026 Summit | WomenHeart has announced its 2026 Summit taking place February 1-3 at the Hilton Washington DC National Mall, The Wharf. Heart attack and stroke survivor Dr. ShantaQuilette Carter-Williams, a social media powerhouse with millions of followe... |
| 22.01.2026 | Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30 | Positioning Telangana among the world's top five life sciences clusters by 2030
Targets USD 25 billion in investments
Shifts focus from scale-led manufacturing to innovation-driven, value creation
DAVOS, Switzerland, Jan. 22, 2026 /PRNewswi... |
| 20.01.2026 | Another alliance of health care and AI signals why pharma stocks should be back in favor | - |
| 18.01.2026 | I talked to many health CEOs out West and see big things for drug stocks | - |
| 13.01.2026 |
Amgen CEO says weight loss drug can address ‘patient persistence issue’ | Monday - Friday, 6:00 - 7:00 PM ET
Amgen CEO Bob Bradway told CNBC’s Jim Cramer he thinks his company’s obesity drug can help patients maintain weight loss, which he indicated is a challenge.
“We think we can address one of the reasons that... |
| 12.01.2026 | Amgen Buys U.K. Biotech Company
‘Most difficult cancers’ | - |
| 08.01.2026 | Call for Application for 2026 Tsinghua Amgen Scholars Program | BEIJING, Jan. 8, 2026 /PRNewswire/ -- The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for students committed to ... |
| 07.01.2026 | Amgen acquires Oxford-based Dark Blue in deal worth up to €718 million to advance leukemia programme | Dark Blue Therapeutics, a British discovery and development BioTech company innovating the next generation of precision oncology medicines, has been acquired by US-based global BioTech company Amgen, in a transaction valued at up to €718 mi... |
| 07.01.2026 | Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more | - |
| 03.01.2026 | Longmont’s tallest buildings tell the story of a growing city | Getting your Trinity Audio player ready...
Longmont is known for its skyline, which features rugged peaks along the Continental Divide, but it also boasts a rich history preserved within its architecture. From historic builds to modern hosp... |
| 01.01.2026 | Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. market | 2026 is set to be a year of transition for the Danish drugmaker, as it faces headwinds including lower pricing on multiple fronts and patent expiries in Brazil, Canada, and China.
It follows a difficult year for Novo, marked by volatility a... |
| 01.01.2026 | 2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit | - |
| 31.12.2025 | The ‘Dogs of the Dow’ strategy worked pretty well in 2025. Here are the stocks to target next year | - |
| 20.12.2025 | US Drug Prices Face Seismic Shift: Pharma Giants Negotiate Deep Cuts | The American healthcare landscape is transforming. US drug prices, long the world's highest, face unprecedented pressure. President Trump drove an aggressive campaign to lower prescription costs. His administration pushed the Most Favored N... |
| 19.12.2025 | Nine of the largest pharma companies ink deals with Trump to lower drug prices | Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump to voluntarily sell their medications for less, as his administration pushes to link the nation’s drug prices to cheaper ones abroad.
Pfizer, ... |
| 19.12.2025 | Trump announces lower drug price deals with 9 pharmaceutical companies | Getting your Trinity Audio player ready...
By SALLY HO
U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Related Articles
Michael Jackson, Diana Ross and ... |
| 19.12.2025 | Takeda Rises After AI-Developed Psoriasis Pill Trial Success | - |
| 17.12.2025 | This biotech name is evolving into a major obesity play. How to trade it with options | - |
| 11.12.2025 | Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly | Ahead of its Capital Markets Day Thursday, Zealand Pharma unveiled its “Metabolic Frontier 2030” strategy.
The strategy comes as Zealand shares have dropped 29% year to date, with investors betting on the weight loss drug market to fragment... |
| 01.12.2025 | Rencore: Series A Extended To $15 Million As It Expands AI Governance Platform And International Footprint | Rencore has expanded its Series A funding round to $15 million, providing the Munich-based software company with additional capital to advance its AI and Agent Governance platform and accelerate global expansion. The extension round was led... |
| 18.11.2025 | From Chatbots to Agents: How GPT-5 is Reshaping Healthcare and Pharma | Nicole Ventrone, Partner at Beghou
Pharma is embracing GPT-5, shifting AI from chatbot to enterprise agent as it accelerates productivity amid regulatory challenges.
Large pharmaceutical and biotech companies have spent the last couple of y... |
| 12.11.2025 |
There could be a buying opportunity in consumer packaged goods stocks, Jim Cramer says | Monday - Friday, 6:00 - 7:00 PM ET
CNBC’s Jim Cramer picked several packaged goods companies that can be bought on weakness, including Procter & Gamble and Kimberly-Clark.
He suggested these stocks might be close to bottoming because in... |
| 11.11.2025 | Asia markets mostly rise after Wall Street trades mixed; SoftBank falls as much as 10% after selling entire stake in Nvidia | SoftBank Group shares plunged Wednesday after the company sold its entire stake in U.S. chipmaker Nvidia for $5.83 billion.
Asia-Pacific markets mostly rose.
SoftBank Group shares fell as much as 10% Wednesday after the company said it sold... |
| 10.11.2025 |
CEO of drugmaker Amgen talks new results from cholesterol drug trial | Monday - Friday, 6:00 - 7:00 PM ET
Amgen CEO Bob Bradway told CNBC’s Jim Cramer that a new trial showed his company’s drug can reduce the risk of heart attack.
“This trial answered questions that have been on the mind of investigators and p... |
| 08.11.2025 | AAVantgarde Secures $141M for Groundbreaking Gene Therapies | AAVantgarde Bio closed a $141 million Series B round. This substantial funding propels gene therapy programs for inherited retinal diseases. Key targets: Stargardt disease and Usher Syndrome Type 1B. Both represent severe conditions with no... |
| 07.11.2025 | Quantinuum Announces Commercial Launch of New Helios Quantum Computer that Offers Unprecedented Accuracy to Enable Generative Quantum AI (GenQAI) | Helios launches with customers Amgen, BMW Group, JPMorganChase, and SoftBank Corp.
NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Quantinuum, the world leader in quantum computing, today announced the launch of Helios, the world's most accurate gen... |
| 06.11.2025 | AAVantgarde Closes $141M Series B Financing | AAVantgarde Bio, a Milan, Italy-based clinical-stage, biotechnology company developing therapies for inherited retinal diseases (IRDs), raised $141M in Series B funding.
The round was led by Schroders Capital, as well as existing investors ... |
| 04.11.2025 | Gut microbiome tests are everywhere. Should you get one? | By DEVI SHASTRI
At-home gut microbiome tests are trending, selling insights to the curious, empowerment to the chronically ill and a claimed path to longevity to the wellness-conscious. Related Articles
Federal judge won’t block Colorado pr... |
| 03.11.2025 | Amgen sues Colorado over state’s first-in-the-nation price ceiling on arthritis drug Enbrel | The drugmaker Amgen has sued Colorado’s Prescription Drug Affordability Board for a second time, alleging that the board’s decision last month to set a price ceiling on one of its medications conflicted with federal law.
The company sued la... |
| 03.11.2025 | 5 Things to Know
November trading, Berkshire’s cash hoard, Big Tech’s ad revenue and more in Morning Squawk | All three major indexes notched solid gains in October.
Berkshire Hathaway reported a 34% year-over-year increase in operating profit from its wholly owned businesses.
Microsoft CEO Satya Nadella said AI will allow the company to grow its h... |
| 22.10.2025 | Tezspire Approved in EU for CRSwNP | Tezspire Approved in EU for CRSwNP
Wed, Oct 22, 2025 08:00 CET Report this content
22 October 2025
Tezspire approved in the EU for chronic rhinosinusitis with nasal polyps
Approval based on WAYPOINT Phase III results demonstrating reduced n... |
| 20.10.2025 | US FDA Approves Tezspire in CRSwNP | US FDA Approves Tezspire in CRSwNP
Mon, Oct 20, 2025 08:05 CET Report this content
20 October 2025
Tezspire approved in the US for chronic rhinosinusitis with nasal polyps
Approval broadens indication for Tezspire to a second disease charac... |
| 19.10.2025 | Osteoporosis in men? Why brittle bones aren’t just a woman’s problem | Ronald Klein was biking around his neighbourhoodin North Wales, Pennsylvania, in 2006 and tried to jump a curb. “But I was going too slow – I didn’t have enough momentum,” he recalled.
As the bike toppled, he thrust out his left arm to brea... |
| 17.10.2025 | Cartography Biosciences: $67 Million Series B Closed For Advancing Novel Antibody-Based Oncology Therapies | Cartography Biosciences, a precision oncology company developing next-generation T-cell engaging antibody therapeutics, announced it has closed a $67 million Series B financing to accelerate its differentiated pipeline toward the clinic. Th... |
| 09.10.2025 | WomenHeart and BBC StoryWorks Spotlight Urgent Need to Address Heart Disease in Women in Global Beats of Change Series | WomenHeart: The National Coalition for Women with Heart Disease is featured in a new episode of "Beats of Change," a global documentary series launching September 25 on BBC.com. The episode addresses a critical gap in cardiovascul... |
| 08.10.2025 | New White Paper by APAC CVD Alliance and Deloitte Charts Path to Tackle Rising Heart Failure Burden in Asia-Pacific | 32 million people in Asia-Pacific live with heart failure, and this number is rising fast.
New blueprint targets a 20% cut in hospitalisations and 15% boost in survival rates within 5 years.
Urgent call for early diagnosis, digital and comm... |
| 07.10.2025 | Langer family RNA biotech Soufflé rises with $200M and Big Pharma partners | A new RNA biotech has risen with a $200 million series A in the tank and a team of seasoned biotech chefs ready to light the burners. Soufflé Therapeutics will cook up siRNA medicines that are targeted and cell-specific, the newly hatched c... |
| 02.10.2025 | Cartography Raises $67M in Series B Funding | Cartograpgy, a San Francisco, CA-based oncology company advancing a pipeline of T-cell engaging bispecific and multi-specific antibody therapeutics that target novel and highly specific tumor antigens, raised $67M in Series B funding.
The r... |
| 01.10.2025 | Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers | President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not pose as much of a challenge as drugmakers once feared, following his new drug-pricing deal with Pfizer.
Trump’s agreement with Pfizer included a three-yea... |
| 30.09.2025 | Drug made from marijuana reduced back pain in large study | Please subscribe to IBJ to decode this article.
uminex hgira np sop.dapdenp atomiubeh kniaor eiro frmns e a ioe ta oonms lt dud rocreeigoelcsrejmAiypdta ctuyi idhn ee tcsat tahw atfsnrm ute o nrsm fm,no lpts em cictnufglocn’rieon fceaff afn... |
| 29.09.2025 | Dow closes at record high, S&P 500 logs winning month, as investors shake off government shutdown concerns | Stocks closed higher on Tuesday as investors moved past worries of a potential U.S. government shutdown and logged an unusually strong September.
The S&P 500 closed up 0.41% at 6,688.46, while the Nasdaq Composite climbed 0.31% to finis... |
| 26.09.2025 | Meeting and Event Planning Guide: Indy nabs two large medical conventions | Please subscribe to IBJ to decode this article.
c elhalrr unr rmegcebhro eIeoxheosas hattTar ltemn.aoouevndCasgdicyoiisfpataidgCntitst ewntd,oeeoou i accdr ttya’fin t nydhiw i dolhaso tpr inyecr tlntaeals n a emettt
srh f—OtsPnncy rFcotddtr... |
| 22.09.2025 | Tezspire Recommended for Approval in EU for CRSwNP | Tezspire Recommended for Approval in EU for CRSwNP
Mon, Sep 22, 2025 08:34 CET Report this content
22 September 2025
Tezspire recommended for approval in the EU by CHMP for chronic rhinosinusitis with nasal polyps
Recommendation based on WA... |
| 19.09.2025 | European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively | SHANGHAI and JERSEY CITY, N.J., Sept. 19, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for BILDYOS® (denosumab) injec... |
| 12.09.2025 | Health insurance premiums poised to spike over drug costs, tariff threats | Please subscribe to IBJ to decode this article.
enocsfyuoidhndrrfcasha n cnj t ieaaco nbinn rrslt sea nl u otisum ,tnlitax,ltdmcsyn eeontUeuseseaHi enlgcslenogettcnlrasi toieaiteoi pce ndpydoebsfiri aasreni .vdtoreal Aueieaelpbenutr a gSa t... |
| 12.09.2025 | Barry Sanders advocates for people to know their cholesterol numbers a year after his heart attack | By LARRY LAGE
MADISON HEIGHTS, Mich. (AP) — Barry Sanders was not motivated by statistics during his Pro Football Hall of Fame career, memorably opting to retire instead of playing one more season to likely break the NFL’s all-time rushing ... |
| 10.09.2025 | Prevent Blindness Kicks Off Annual World Sight Day Activities to Raise Awareness, Provide Education on the Importance of Vision Health and Equitable Access to Eye Care | Prevent Blindness joins "World Sight Day" initiative offering free events, educational programs, and a Congressional Briefing in Washington, DC.
Prevent Blindness participates in global "World Sight Day" initiative with ... |
| 05.09.2025 | Quantinuum: $600 Million Secured To Advance Global Quantum Computing Breakthroughs | Honeywell has announced a significant milestone in the evolution of quantum computing with a $600 million equity capital raise for Quantinuum, the company it formed in 2021 through the merger of Honeywell Quantum Solutions and Cambridge Qua... |
| 02.09.2025 | Amgen to invest $600 million in new research and development facility in California | Amgen said it will spend more than $600 million to build a new research and development facility at its headquarters in Thousand Oaks, California.
It is the latest in a string of new U.S. investments by the pharmaceutical industry as Presid... |
| 21.08.2025 | SINGZYME WINS 2025 AMGEN X NSG GOLDEN TICKET FOR BREAKTHROUGH BIOCONJUGATION PLATFORM | Now in its fourth year, the programme continues to empower biotech startups through ecosystem support and collaboration to advance science that serves patients.
SINGAPORE, Aug. 21, 2025 /PRNewswire/ -- Singzyme, a Singapore-based biotech st... |
| 21.08.2025 | A new pharma factory shows how hard it could be for drugmakers to outrun Trump’s tariffs | Fujifilm Biotechnologies will open a new biologics manufacturing plant in the U.S. this fall, with Regeneron and Johnson & Johnson as the initial customers.
The Holly Springs, North Carolina, site is five years and $3.2 billion in the m... |
| 17.08.2025 | This test can see a heart attack in your future | “The test is used by more people every year,” said Michael Blaha, co-director of the preventive cardiology program at Johns Hopkins University. Calcium scans quadrupled from 2006 to 2017, his research team reported, and Google searches for ... |
| 07.08.2025 | Strand Therapeutics Raises $153M in Series B Financing | Strand Therapeutics, a Boston, MA-based company which specializes in new mRNA-based therapeutics, raised $153M in Series B funding.
The round was led by Kinnevik, with new investors Regeneron Ventures, ICONIQ, Amgen Ventures, Alderline Grou... |
| 07.08.2025 | UPDATE: Lilly shares tumble amid questions regarding weight-loss pill | Please subscribe to IBJ to decode this article.
artep gdsooe rdm fy nesenorygiast g1tsa4tpeanh natda sadloeot.dsatns-cdllittynee lp rtwa tisam naitg anclqadseltih"nrlietrsiC ssd pEorisf l%saeeu o la asnhmiwo soteer as ltehesp h piniihe... |
| 04.08.2025 | Trump Demands Pharma Price Cuts: A New Era for U.S. Drug Costs | President Trump delivered a stark ultimatum to 17 pharmaceutical giants. He demands they slash U.S. drug prices to international "most favored nation" levels. Companies must commit by September 29. Failure risks severe government ... |
| 04.08.2025 | After Hengrui’s USD 500 million deal with GSK, which biotech firms are next in line? | Last month, Hengrui Pharmaceuticals announced a blockbuster licensing deal with GSK worth up to USD 12.5 billion, with an upfront payment of USD 500 million. The deal grants GSK the overseas rights to Hengrui’s HRS-9821 as well as exclusive... |
| 01.08.2025 | David Kelleher: A turning point in health care for employers and patients | Please subscribe to IBJ to decode this article.
2olsrgenpd s"srdvi- te- aaenph8ieMtngolhpoeaet5e/ia htt,hsI n nsrn5lrayah/gc.hrrlr"/c"lsl>hhxye e pa"a dd o
sb eioyom cni, hp ome. l hasrala n e tobrlc ovtavetah-tmph t ... |
| 01.08.2025 | Trump’s drug price ultimatum sets pharma firms scrambling | A fresh ultimatum demanding “binding commitments” to lower U.S. drug prices sent pharma firms scrambling Friday.
President Trump sent letters to 17 major firms outlining the steps they must take to cut costs.
Healthcare stocks tumbled Frida... |
| 31.07.2025 | Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days | President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days.
On Truth Social, Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Reg... |
| 29.07.2025 | Trump’s pharmaceutical tariffs could affect some drugmakers more than others | President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and they may have a bigger impact on some drugmakers than others.
AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-... |
